Sources

4 Total Sources

Aleniglipron Pill Delivers 12.1% Weight Loss in 36 Weeks in Phase II Trial

ScienceDaily10d ago

Aleniglipron Oral GLP-1 Pill Shows 12.1% Weight Loss in Phase II Trial

BioSpace10d ago

Kailera, Hengrui Push Oral GLP-1/GIP Pill to Phase 3 After Clearing Mid- Stage China Study - BioSpace

pabau.com10d ago

65 GLP-1 Statistics for 2026 (Every Figure Sourced) | Pabau

Instagram10d ago

GLP-1 drugs changed the weight-loss conversation almost overnight. Medicines first built for diabetes suddenly became some of the most wanted treatments in the world because they help many people lose significant weight